Presentation
Nutritional approach:
Poor nutrition is the main factor responsible for obesity, type II diabetes, and cardiovascular disease in western societies. Western diets include large amounts of saturated fat and fructose in soft drinks 1, both of which foster a “cardiometabolic syndrome”.
Integrated solutions:
Lipid, lipoprotein and glucose metabolic disorders are interconnected and cause several human diseases 2 3 4. For example, two-thirds of deaths among diabetic patients are due to cardiovascular disorders. This underlines the importance of being able to measure direct as well as indirect effects of medicines in integrated animal models and/or panels of complementary models of glucose, lipid and lipoprotein disturbances.
While genetic models can provide answers to specific questions, Physiogenex is convinced that the nutritional approach is the best solution for obtaining a thorough pathophysiological picture of the human “cardiometabolic syntrome”. Nevertheless, the two approaches can be combined when needed.
Physiogenex has acquired unique expertise on diets, animal strains, housing/breeding conditions, and technological tools to overcome common bottlenecks:
- managing phenotypic changes according to diet composition, as well as the nature and age of the animal strain,
- selecting homogenous populations in order to improve sensitivity and to provide reproducible and validated data
The following marketed drugs were validated in our models: biguanide, thiazolidinedione, CB1 antagonist, GLP-1 analog, DPP4 inhibitor, statins, fibrates, etc.
Over the years, several drugs have been validated with Physiogenex’s models including PTP1b inhibitor, 11βHSD1 inhibitor, glucokinase activator, adiponectin-like peptide, SCD1 inhibitor, MC4R agonist, CB1 antagonists and intestinal lipase inhibitor.
(1) "Drinking more than one soft drink daily was associated with a 44% greater risk of developing the metabolic syndrome and four out of five components (waist circumference, fasting glucose, hypertriglyceridemia and low HDL-c) of the metabolic syndrome". Source: Dhingra R, Sullivan L, Jacques PF, et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 2007; DOI: 10.1161/circulationaha.107.689935. Available at: http://circ.ahajournals.org
(2) McGavock JM, Lingvay I, Zib I, et al. Cardiac steatosis in diabetes mellitus: A 1H-magnetic resonance spectroscopy study. Circulation 2007; 116:1170-1175
(3) Ruberg F. Myocardial lipid accumulation in the diabetic heart. Circulation 2007; 116:1110-1113.
(4) www.theheart.org
Tailor-made predictive solutions
1st STEP: to define the best conditions
